Compound
D0053 | Farglitazar
| (2S)-2-[[2-(benzoyl)phenyl]amino]-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propanoic acid | (S)-2-((2-Benzoylphenyl)amino)-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid | (S)-2-(2-Benzoyl-phenylamino)-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-propionic acid |
| (S)-2-(2-benzoylphenylamino)-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid | 196808-45-4 | 1fm9 |
| 2(S)-(2-Benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenyl]propionic acid | 2-(2-BENZOYL-PHENYLAMINO)-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-PROPIONIC ACID | 2-(2-Benzoyl-phenylamino)-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-propionic acid(GI 262570) |
| 3433GY7132 | BDBM50085044 | CAS-196808-45-4 |
| CHEMBL107367 | D04132 | DSSTox_CID_27310 |
| DSSTox_GSID_47310 | DSSTox_RID_82260 | DTXSID1047310 |
| Farglitazar | Farglitazar (USAN/INN) | Farglitazar [USAN:INN] |
| Farglitazar [USAN] | GI 262570 | GI 262570X |
| GI-262570 | GI-262570X | GI262570 |
| GI262570X | GTPL2672 | KBio2_002347 |
| KBio2_004915 | KBio2_007483 | KBioGR_002347 |
| KBioSS_002350 | L-Tyrosine, N-(2-benzoylphenyl)-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]- (9CI) | L-Tyrosine, N-(2-benzoylphenyl)-o-(2-(5-methyl-2-phenyl-4-oxazolyl)ethyl) |
| L-Tyrosine, N-(2-benzoylphenyl)-o-(2-(5-methyl-2-phenyl-4-oxazolyl)ethyl)- | L-tyrosine, N-(2-benzoylphenyl)-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]- | LS-184758 |
| N-(o-Benzoylphenyl)-O-(2-(5-methyl-2-phenyl-4-oxazolyl)ethyl)-L-tyrosine | NCGC00247940-01 | NCGC00254050-01 |
| O-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethyl]-N-[2-(phenylcarbonyl)phenyl]-L-tyrosine | Q5435087 | SCHEMBL501024 |
| Tox21_300218 | UNII-3433GY7132 | ZINC49639808 |
| ZZCHHVUQYRMYLW-HKBQPEDESA-N | cMAP_000025 |
| CAS Number | 196808-45-4 |
| PubChem Compound | 170364 |
| KEGG Drug | D04132 |
| PharmGKB | PA165815771 |
| ChemSpider | 148961 |
| Wikipedia | Farglitazar |
1. Brunmair et al. (2004)